# Bionter

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bionter

- Industry: Medical Devices & Equipment
- Headquarters: Switzerland
- Website: www.bionter.com
- Total disclosed funding: $3M
- Latest round: Seed (Apr 27, 2022)
- Investors on record: 1

## About

Based in Riehen, Switzerland, and founded in 2020 by Tobias Werk, Bionter AG takes care of particle testing, for patient safety and sub-visible particle testing particles is considered very important. In April 2022, Bionter AG raised USD 3 million in seed funding led by new investor Dynamk Capital.


The company provides particle counters that help pharmaceutical and biotechnology companies to count and analyze sub-visible particles. The firm’s first product is EVE particle counter which is fully automated and counts subvisible particles with a non-destructive sample testing.


The company will use April 2022, funding to launch its first product solution this year, grow its team and further innovate the product offerings.

## Funding rounds

- Seed, Apr 27, 2022, $3M — Dynamk Capital

## Investors

- Dynamk Capital (https://capitalatlas.ai/funds/dynamk-capital) — Seed